Addex Therapeutics Ltd
ADXN
$6.07
$0.132.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -99.19% | -- | |||
| Total Other Revenue | -21.37% | -43.76% | |||
| Total Revenue | -68.06% | 40.59% | |||
| Cost of Revenue | -76.84% | 0.42% | |||
| Gross Profit | 79.27% | 6.96% | |||
| SG&A Expenses | 43.62% | -0.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.75% | -0.03% | |||
| Operating Income | -12.08% | 2.05% | |||
| Income Before Tax | -16.40% | 16.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.40% | 16.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.62% | 11.66% | |||
| EBIT | -12.08% | 2.05% | |||
| EBITDA | -12.09% | 1.78% | |||
| EPS Basic | -11.43% | 21.17% | |||
| Normalized Basic EPS | -11.93% | 26.35% | |||
| EPS Diluted | -11.43% | 21.17% | |||
| Normalized Diluted EPS | -11.93% | 26.35% | |||
| Average Basic Shares Outstanding | 4.62% | 12.09% | |||
| Average Diluted Shares Outstanding | 4.62% | 12.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||